`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE NORTHERN DISTRICT OF WEST VIRGINIA
`MERCK SHARP & DOHME CORP.,
`Plaintiff/Counter-Defendant,
` CIVIL ACTION NO. 1:19CV101
` (Judge Keeley)
`
`v.
`
`•
`
`MYLAN PHARMACEUTICALS INC.,
`Defendant/Counter-Claimant.
`ORDER
`On August 1, 2019, the Court held a scheduling conference
`(Dkt. No. 47), and for the reasons stated on the record:
`SCHEDULED a status conference by telephone for Monday,
`•
`August 24, 2020, at 12:15 P.M.;
`CONDITIONALLY SCHEDULED a three-day trial to begin on
`December 13, 2021; and
`DIRECTED the parties to submit quarterly status reports,
`if the Judicial Panel on Multidistrict Litigation grants
`the unopposed motion to transfer filed by the plaintiff,
`Merck Sharp & Dohme Corp.
`Counsel for the defendant, Mylan Pharmaceuticals Inc., is
`DIRECTED to provide call-in information to the parties and the
`Court, by email to Candace_Levitsky@wvnd.uscourts.gov, no later
`than Friday, August 21, 2020, at 5:00 P.M..
`It is so ORDERED.
`
`•
`
`Merk Sharp & Dohme Corp. Exhibit 2007
`Mylan Pharmaceuticals Inc. v. Merk Sharp & Dohme Corp.
`IPR2020-00040
`Page 1
`
`
`
`Case 1:19-cv-00101-IMK Document 48 Filed 08/02/19 Page 2 of 2 PageID #: 690
`
`MERCK V. MYLAN
`
` 1:19CV101
`
`ORDER
`The Clerk is directed to transmit copies of this Order to
`counsel of record.
`DATED: August 2, 2019
`
`/s/ Irene M. Keeley
`IRENE M. KEELEY
`UNITED STATES DISTRICT JUDGE
`
`Merk Sharp & Dohme Corp. Exhibit 2007
`Mylan Pharmaceuticals Inc. v. Merk Sharp & Dohme Corp.
`IPR2020-00040
`Page 2
`
`